Pomerantz LLP has initiated a securities investigation into Danone S.A. following the discovery of cereulide toxin in its Dumex Dulac 1 infant formula manufactured in Thailand. The contamination prompted the company to issue product recalls on January 21 and January 23, 2026, affecting its consumer health division and triggering immediate market reaction.
The announcements corresponded with notable declines in Danone's share price, with the stock falling 7.95% following the first recall announcement and an additional 2.7% decline after the second recall. The investigation will examine whether the company's disclosures to investors regarding product safety and quality control were adequate and timely prior to the public recall notices.
Infant formula safety incidents represent a critical area of regulatory and investor scrutiny, as any contamination of such products carries significant health, legal, and financial implications for manufacturers. The investigation follows standard protocols for examining potential securities violations in cases where material corporate events substantially impact shareholder value.